The 18 references in paper A. Unanyan L., V. Alimov A., S. Arakelov E., M. Afanasyev S., D. Baburin V., D. Blinov V., T. Guriyev D., U. Zimovina V., A. Kadyrova E., Yu. Kossovich M., L. Polonskaya S., А. Унанян Л., В. Алимов А., С. Аракелов Э., М. Афанасьев С., Д. Бабурин В., Д. Блинов В., Т. Гуриев Д., У. Зимовина В., А. Кадырова Э., Ю. Коссович М., Л. Полонская С. (2015) “Фармакоэпидемиология использования оригинального дротаверина при дисменорее: результаты международного многоцентрового исследования // PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY” / spz:neicon:pharmacoeconomics:y:2014:i:3:p:44-50

1
Vozovik A.V., Bazhukova N.N. Reproduktivnoe zdorov'e detei i podrostkov. 2008; 5: 40-42.
(check this in PDF content)
2
Dadak K. Akusherstvo, ginekologiya i reproduktsiya. 2013; 2: 6-14.
(check this in PDF content)
3
Dzhamberardino M.A. Visceral pain. International Association for the Study of Pain, updated clinical information on pain [Vistseral'naya bol'. Mezhdunarodnaya assotsiatsiya po izucheniyu boli, obnovlenie klinicheskoi informatsii po boli]. Available at: http:// www.iasppain.org. Access was made in December 2011. 2005; XIII (6): 1-6.
(check this in PDF content)
4
Dzhobava E.M., Loginova K.B. Dismenoreya. Akusherstvo i Ginekologiya. 2014; 11: 22-27.
(check this in PDF content)
5
Gevorkyan M.A., Blinov D.V., Smirnova S.O. Akusherstvo, ginekologiya i reproduktsiya. 2012; 1: 39-49.
(check this in PDF content)
6
Gynecology. National leadership. Ed. VI Kulakov, GM Savelyev, IB Manukhina [Ginekologiya. Natsional'noe rukovodstvo. Pod red. V.I. Kulakova, G.M. Savel'evoi, I.B. Manukhina]. Moscow. 2009.
(check this in PDF content)
7
Gromova O.A., Limanova O.A., Torshin I.Yu. Akusherstvo, ginekologiya i reproduktsiya. 2013; 3: 35-50.
(check this in PDF content)
8
Elizavetina G.A., Minushkin O.N. Consilium medicum. 2011; 8: 57-60.
(check this in PDF content)
9
Leonova M.V. Clinical pharmacology No-spa. Toolkit [Klinicheskaya farmakologiya No-shpa. Metodicheskoe posobie]. Moscow. 2011.
(check this in PDF content)
10
Mezhevitinova E.A., Kuzemin A.A. Ginekologiya. 2001; 3 (4): 34-37.
(check this in PDF content)
11
Nesterovskaya I.V., Osipova A.A. Akusherstvo, ginekologiya i reproduktsiya. 2008; 6: 11-14.
(check this in PDF content)
12
Romiks I., Molnar D.L., Timberg G., Mrklich B., Dzhelakovich B., Kozhegi G., Blasko G.. Bi Dzhei Yu Int. 2003; 92: 92-96.
(check this in PDF content)
13
Cherkasova N.Yu., Fomina A.V., Filippova O.V. Farmakoekonomika. Sovremennaya farmakoekonomika i farmakoepidemiologiya. 2013; 3: 36-40.
(check this in PDF content)
14
Hamza M. Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme Inhibition. Curr Mol Pharmacol. 2009; 2 (1): 1-14.
(check this in PDF content)
15
Kelly R.W., King A.E., Critchley H.O. Cytokine control in human endometrium. Reproduction. 2001; 21 (1): 3-19.
(check this in PDF content)
16
Lete L.I. Improvement of dysmenorrhea and premenstrual syndrome in NuvaRing users - a clinical experience program in Spain. Eur J Contracept Reprod Health Care. 2006; 11 (1): 56.
(check this in PDF content)
17
Lundstrom V., Green K. Endogenous levels of prostaglandin F2 and its metabolites in plasma and endometrium of normal and dysmenorrheic women. Am J Obstet Gynecol. 1978; 130: 640-646.
(check this in PDF content)
18
Milsom I., Sundell G., Andersch B. The influence of different combined oral contraceptives on the prevalence and severity of dysmenorrheal. Contraception. 1990; 42: 497-506. PHARMACOEPIDEMIOLOGY OF ORIGINAL DROTAVERINE USE IN DYSMENORRHEA: RESULTS OF AN INTERNATIONAL MULTICENTER STUDY
(check this in PDF content)